Oral therapy for type 1 diabetes mellitus using a novel immunomodulator, FTY720 (fingolimod), in combination with sitagliptin, a dipeptidyl peptidase‐4 inhibitor, examined in non‐o...

Por Tsuji, Takumi, Yoshida, Yuya, Fujita, Tetsuro, Kohno, Takeyuki
Publicado em 2012

Therapeutic approach for type 1 diabetes mellitus using the novel immunomodulator FTY720 (fingolimod) in combination with once‐daily injection of insulin glargine in non‐obese diab...

Por Tsuji, Takumi, Inoue, Mariko, Yoshida, Yuya, Fujita, Tetsuro, Kaino, Yukikazu, Kohno, Takeyuki
Publicado em 2011

Sli2 (Ypk1), a Homologue of Mammalian Protein Kinase SGK, Is a Downstream Kinase in the Sphingolipid-Mediated Signaling Pathway of Yeast

Por Sun, Yidi, Taniguchi, Ritsuko, Tanoue, Daisuke, Yamaji, Toshiyuki, Takematsu, Hiromu, Mori, Kazutoshi, Fujita, Tetsuro, Kawasaki, Toshisuke, Kozutsumi, Yasunori
Publicado em 2000

SLI1 (YGR212W) is a major gene conferring resistance to the sphingolipid biosynthesis inhibitor ISP-1, and encodes an ISP-1 N-acetyltransferase in yeast

Por Momoi, Michiko, Tanoue, Daisuke, Sun, Yidi, Takematsu, Hiromu, Suzuki, Yusuke, Suzuki, Minoru, Suzuki, Akemi, Fujita, Tetsuro, Kozutsumi, Yasunori
Publicado em 2004

Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose‐6‐phosphate isomerase peptide‐induced arthritis

Por Yoshida, Yuya, Mikami, Norihisa, Matsushima, Yuki, Miyawaki, Mai, Endo, Hiroki, Banno, Rie, Tsuji, Takumi, Fujita, Tetsuro, Kohno, Takeyuki
Publicado no Immun Inflamm Dis (2016)